Compare Organon Pharma Indonesia Tbk. (SCPI) vs Sarana Mitra Luas Tbk. (SMIL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Organon Pharma Indonesia Tbk. vs Sarana Mitra Luas Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Sarana Mitra Luas Tbk. trades at Rp434 (market cap 3.87T, 61.37M 24h volume). The key difference: Sarana Mitra Luas Tbk. is far larger — about 37.1× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| SCPI | SMIL | |
|---|---|---|
Market Cap | 104.4B | 3.87T |
Volume | — | 61.37M |
Lot | — | 613.69K |
Turnover | — | 27.25B |
Average Price | — | 444.04 |
Value | — | 27.25B |
Indicative Equilibrium Price | — | 434 |
Indicative Equilibrium Volume | — | 46.4K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →About Sarana Mitra Luas Tbk.
PT Sarana Mitra Luas Tbk (the Company) was established on Sep 28, 2006 based on Notarial Deed No. 06 of Fransiska Bonita Maya Dwi Tanti, S.H., notary in Bekasi. The Company started its commercial operations in 2006.
Read more on SMIL →
